Skip to main content

SILICON LABORATORIES INC

For the period ended Dec 28, 2024. Filed Feb 4, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 4, 2025

SLAB$221.80+0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets at and

Consolidated Balance Sheets

(In thousands, except per share data)

December 28,2024December 30,2023
Assets
Current assets:
Cash and cash equivalents$281,607$227,504
Short-term investments100,554211,720
Accounts receivable, net54,47929,295
Inventories105,639194,295
Prepaid expenses and other current assets59,75475,117
Total current assets602,033737,931
Property and equipment, net132,136145,890
Goodwill376,389376,389
Other intangible assets, net36,49959,533
Other assets, net75,617123,313
Total assets$1,222,674$1,443,056
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$42,448$57,498
Revolving line of credit—45,000
Deferred revenue and returns liability3,0732,117
Other current liabilities52,36258,955
Total current liabilities97,883163,570
Other non-current liabilities44,77070,804
Total liabilities142,653234,374
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued——
Common stock – $0.0001 par value; 250,000 shares authorized; 32,458 and 31,897 shares issued and outstanding at December 28, 2024 and December 30, 2023, respectively33
Additional paid-in capital78,22716,973
Retained earnings1,001,7211,192,731
Accumulated other comprehensive income (loss)70(1,025)
Total stockholders’ equity1,080,0211,208,682
Total liabilities and stockholders’ equity$1,222,674$1,443,056
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.